ARTICLE | Company News
PolyMedix infectious news
April 15, 2013 7:00 AM UTC
PolyMedix and its PolyMedix Pharmaceuticals Inc. subsidiary filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. At Dec. 31, 2012, the company had $4.6 million in assets and $11.3 million in total liabilities. PolyMedix also said Edward Smith resigned as acting president, CEO and CFO. Smith was appointed interim president and CEO in January (see BioCentury, Feb. 4). ...